Securing the retatrutide compound in the United States currently presents a hurdle as it's not yet approved for widespread public dispensing. Clinicians participating in research studies may be providing it, but access is constrained to those involved . Independent pharmacies , operating under specific licenses , *might* offer specially prepared ve